Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia

Pharmacotherapy

Volumn 30, Issue 12, 2010, Pages 1229-1238

  Skrupky, Lee P ^a   Smith, Jennifer R ^a   Deal, Eli N ^a   Arnold, Heather ^a   Hollands, James M ^a   Martinez, Emily J ^a   Micek, Scott T ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Argatroban; Bivalirudin; Direct thrombin inhibitor; DTI; Heparin induced thrombocytopenia; HIT; Management

Indexed keywords

ARGATROBAN; HEPARIN; HIRULOG; THROMBIN INHIBITOR; WARFARIN;

ACUTE HEART INFARCTION; ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; CEREBROVASCULAR DISEASE; DEATH; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGICAL PARAMETERS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTENSIVE CARE UNIT; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; RETROSPECTIVE STUDY; THROMBOEMBOLISM; TREATMENT OUTCOME;

ANTITHROMBINS; FEMALE; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PEPTIDE FRAGMENTS; PIPECOLIC ACIDS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TIME FACTORS;

EID: 78650223367     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.12.1229     Document Type: Article

References (23)

1. Shantsila E, Lip GY, Chong BH. Heparin-induced thrombocytopenia: a contemporary approach to diagnosis and management. Chest 2009;135:1651-64.
2. Warkentin TE. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban. Thromb Res 2003;110:73-82.
3. Warkentin TE, Greinacher A, Koster A, Lincoff AM, for the American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia. Chest 2008;133:S340-80.
4. Greinacher A, Janssens U, Berg G, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation 1999;100:587-93.
5. Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, for the Argatroban-915 Investigators. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 2003;163:1849-56.
6. Bott JN, Reddy K, Krick S. Bivalirudin use in off-pump myocardial revascularization in patients with heparin-induced thrombocytopenia. Ann Thorac Surg 2003;76:273-5.
7. Gordon G, Rastegar H, Schumann R, Deiss-Shrem J, Denman W. Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth 2003;17:632-5.
8. Kiser TH, Fish DN. Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction. Pharmacotherapy 2006;26:452-60.
9. Kiser TH, Burch JC, Klem PM, Hassell KL. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia. Pharmacotherapy 2008;28:1115-24.
10. Berilgen JE, Nguyen PH, Baker KR, Rice L. Bivalirudin treatment of heparin-induced thrombocytopenia [abstract]. Blood 2003;102:1969.
11. Francis JL, Drexler A, Gwyn G, Moroose R. Successful use of bivalirudin in the treatment of patients suspected, or at risk of, heparin-induced thrombocytopenia [abstract]. Blood 2004;104:4077.
12. Curzio KM, Cheng-Lai A, Kheyfets V, Sinnet M, Billett HH. A comparison of direct thrombin inhibitors in the treatment of heparin-induced thrombocytopenia: a single institution experience. J Thromb Thrombolysis 2009;28:117-23.
13. Dang CH, Durkalski VL, Nappi JM. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy 2006;26:461-8.
14. Smythe MA, Stephens JL, Koerber JM, Mattson JC. A comparison of lepirudin and argatroban outcomes. Clin Appl Thromb Hemost 2005;11:371-4.
15. GlaxoSmithKline. Argatroban (argatroban) package insert. Research Triangle Park, NC; 2009.
16. Levine RL, Hursting MJ, McCollum D. Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction. Chest 2006;129:1167-75.
17. Reichert MG, MacGregor DA, Kincaid EH, Dolinski SY. Excessive argatroban anticoagulation for heparin-induced thrombocytopenia. Ann Pharmacother 2003;37:652-4.
18. Kodityal S, Nguyen PH, Kodityal A, Sherer J, Hursting MJ, Rice L. Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital. J Intensive Care Med 2006;21:86-92.
19. Beiderlinden M, Treschan TA, Görlinger K, Peters J. Argatroban anticoagulation in critically ill patients. Ann Pharmacother 2007;41:749-54. (Pubitemid 46752654)
20. Begelman SM, Baghdasarian SB, Singh IM, et al. Argatroban anticoagulation in intensive care patients: effects of heart failure and multiple organ system failure. J Intensive Care Med 2008;23:313-20.
21. Brand PA, Egberts JH, Scholz J, Weiler N, Bein B. Argatroban therapy in patients with hepatic and renal impairment. Eur J Anaesthesiol 2008;25:344-6. (Pubitemid 351365294)
22. Arpino PA, Hallisey RK. Effect of renal function on the pharmacodynamics of argatroban. Ann Pharmacother 2004;38:25-9.
23. Lewis BE, Wallis DE, Berkowitz SD, for the ARG-911 Study Investigators. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 2001;103:1838-43.